North America Cancer Treatment Drugs Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Publisher Name :
Date: 10-Jan-2018
No. of pages: 121

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Scope of the Report:

This report focuses on the Cancer Treatment Drugs in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

- Roche

- Novartis

- Celgene

- Bristol-Myers Squibb

- Amgen

- Johnson & Johnson

- Pfizer

- Takeda

- Eli Lilly

- AstraZeneca

- Astellas

- Merck & Co.

- Sanofi

- Bayer

- Biogen Idec

- Eisai

- Teva

- Otsuka

- Merck KGaA

- Ipsen

- AbbVie

- Gilead Sciences

Market Segment by Countries, covering

- United States

- Canada

- Mexico

Market Segment by Type, covers

- Chemotherapy

- Targeted Therapy

- Immunotherapy

- Hormonal Therapy (Biologic Therapy)

- Others

Market Segment by Applications, can be divided into

- Blood Cancer

- Breast Cancer

- Gastrointestinal Cancer

- Prostate Cancer

- Respiratory/Lung Cancer

- Other Cancers

There are 15 Chapters to deeply display the North America Cancer Treatment Drugs market.

Chapter 1, to describe Cancer Treatment Drugs Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Cancer Treatment Drugs, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Cancer Treatment Drugs, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Cancer Treatment Drugs market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Cancer Treatment Drugs Research Findings and Conclusion, Appendix, methodology and data source

North America Cancer Treatment Drugs Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Table of Contents
1 Market Overview
1.1 Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Hormonal Therapy (Biologic Therapy)
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Profile
2.1.2 Cancer Treatment Drugs Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Roche News
2.2 Novartis
2.2.1 Profile
2.2.2 Cancer Treatment Drugs Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Novartis News
2.3 Celgene
2.3.1 Profile
2.3.2 Cancer Treatment Drugs Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Celgene News
2.4 Bristol-Myers Squibb
2.4.1 Profile
2.4.2 Cancer Treatment Drugs Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Bristol-Myers Squibb News
2.5 Amgen
2.5.1 Profile
2.5.2 Cancer Treatment Drugs Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Amgen News
2.6 Johnson & Johnson
2.6.1 Profile
2.6.2 Cancer Treatment Drugs Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Johnson & Johnson News
2.7 Pfizer
2.7.1 Profile
2.7.2 Cancer Treatment Drugs Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Pfizer News
2.8 Takeda
2.8.1 Profile
2.8.2 Cancer Treatment Drugs Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Takeda News
2.9 Eli Lilly
2.9.1 Profile
2.9.2 Cancer Treatment Drugs Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Eli Lilly News
2.10 AstraZeneca
2.10.1 Profile
2.10.2 Cancer Treatment Drugs Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 AstraZeneca News
2.11 Astellas
2.11.1 Profile
2.11.2 Cancer Treatment Drugs Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Astellas News
2.12 Merck & Co.
2.12.1 Profile
2.12.2 Cancer Treatment Drugs Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 Merck & Co. News
2.13 Sanofi
2.13.1 Profile
2.13.2 Cancer Treatment Drugs Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13.4 Business Overview
2.13.5 Sanofi News
2.14 Bayer
2.14.1 Profile
2.14.2 Cancer Treatment Drugs Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14.4 Business Overview
2.14.5 Bayer News
2.15 Biogen Idec
2.15.1 Profile
2.15.2 Cancer Treatment Drugs Type and Applications
2.15.2.1 Type 1
.2.2 Type 2
2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15.4 Business Overview
2.15.5 Biogen Idec News
2.16 Eisai
2.16.1 Profile
2.16.2 Cancer Treatment Drugs Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16.4 Business Overview
2.16.5 Eisai News
2.17 Teva
2.17.1 Profile
2.17.2 Cancer Treatment Drugs Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17.4 Business Overview
2.17.5 Teva News
2.18 Otsuka
2.18.1 Profile
2.18.2 Cancer Treatment Drugs Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18.4 Business Overview
2.18.5 Otsuka News
2.19 Merck KGaA
2.19.1 Profile
2.19.2 Cancer Treatment Drugs Type and Applications
2.19.2.1 Type 1
2.19.2.2 Type 2
2.19.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19.4 Business Overview
2.19.5 Merck KGaA News
2.20 Ipsen
2.20.1 Profile
2.20.2 Cancer Treatment Drugs Type and Applications
2.20.2.1 Type 1
2.20.2.2 Type 2
2.20.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20.4 Business Overview
2.20.5 Ipsen News
2.21 AbbVie
2.21.1 Profile
2.21.2 Cancer Treatment Drugs Type and Applications
2.21.2.1 Type 1
2.21.2.2 Type 2
2.21.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21.4 Business Overview
2.21.5 AbbVie News
2.22 Gilead Sciences
2.22.1 Profile
2.22.2 Cancer Treatment Drugs Type and Applications
2.22.2.1 Type 1
2.22.2.2 Type 2
2.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22.4 Business Overview
2.22.5 Gilead Sciences News
3 North America Cancer Treatment Drugs Market Competition, by Manufacturer
3.1 North America Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Cancer Treatment Drugs Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share
3.4.2 Top 5 Cancer Treatment Drugs Manufacturer Market Share
3.5 Market Competition Trend
4 North America Cancer Treatment Drugs Market Analysis by Countries
4.1 North America Cancer Treatment Drugs Sales Market Share by Countries
4.2 North America Cancer Treatment Drugs Sales by Countries (2012-2017)
4.3 North America Cancer Treatment Drugs Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Cancer Treatment Drugs by Type
5.1 North America Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Cancer Treatment Drugs Sales and Market Share by Type (2012-2017)
5.1.2 North America Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)
5.2 Chemotherapy Sales Growth and Price
5.2.1 North America Chemotherapy Sales Growth (2012-2017)
5.2.2 North America Chemotherapy Price (2012-2017)
5.3 Targeted Therapy Sales Growth and Price
5.3.1 North America Targeted Therapy Sales Growth (2012-2017)
5.3.2 North America Targeted Therapy Price (2012-2017)
5.4 Immunotherapy Sales Growth and Price
5.4.1 North America Immunotherapy Sales Growth (2012-2017)
5.4.2 North America Immunotherapy Price (2012-2017)
5.5 Hormonal Therapy (Biologic Therapy) Sales Growth and Price
5.5.1 North America Hormonal Therapy (Biologic Therapy) Sales Growth (2012-2017)
5.5.2 North America Hormonal Therapy (Biologic Therapy) Price (2012-2017)
5.6 Others Sales Growth and Price
5.6.1 North America Others Sales Growth (2012-2017)
5.6.2 North America Others Price (2012-2017)
6 North America Market Segmentation Cancer Treatment Drugs by Application
6.1 North America Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
6.2 Blood Cancer Sales Growth (2012-2017)
6.3 Breast Cancer Sales Growth (2012-2017)
6.4 Gastrointestinal Cancer Sales Growth (2012-2017)
6.5 Prostate Cancer Sales Growth (2012-2017)
6.6 Respiratory/Lung Cancer Sales Growth (2012-2017)
6.7 Other Cancers Sales Growth (2012-2017)
7 United States Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Cancer Treatment Drugs Sales and Market Share by Type
7.3 United States Cancer Treatment Drugs Sales by Application (2012-2017)
7.4 United States Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Cancer Treatment Drugs Sales and Market Share by Manufacturer
7.4.2 United States Cancer Treatment Drugs Revenue and Market Share by Manufacturer
7.5 United States Cancer Treatment Drugs Export and Import (2012-2017)
8 Canada Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Cancer Treatment Drugs Sales and Market Share by Type
8.3 Canada Cancer Treatment Drugs Sales by Application (2012-2017)
8.4 Canada Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Cancer Treatment Drugs Sales and Market Share by Manufacturer
8.4.2 Canada Cancer Treatment Drugs Revenue and Market Share by Manufacturer
8.5 Canada Cancer Treatment Drugs Export and Import (2012-2017)
9 Mexico Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Cancer Treatment Drugs Sales and Market Share by Type
9.3 Mexico Cancer Treatment Drugs Sales by Application (2012-2017)
9.4 Mexico Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Cancer Treatment Drugs Sales and Market Share by Manufacturer
9.4.2 Mexico Cancer Treatment Drugs Revenue and Market Share by Manufacturer
9.5 Mexico Cancer Treatment Drugs Export and Import (2012-2017)
10 Cancer Treatment Drugs Market Forecast (2017-2022)
10.1 North America Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)
10.2 Cancer Treatment Drugs Market Forecast by Countries (2017-2022)
10.2.1 United States Cancer Treatment Drugs Forecast (2017-2022)
10.2.2 Canada Cancer Treatment Drugs Forecast (2017-2022)
10.2.3 Mexico Cancer Treatment Drugs Forecast (2017-2022)
10.3 Cancer Treatment Drugs Market Forecast by Type (2017-2022)
10.4 Cancer Treatment Drugs Market Forecast by Application (2017-2022)
11 Cancer Treatment Drugs Manufacturing Cost Analysis
11.1 Cancer Treatment Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cancer Treatment Drugs
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Cancer Treatment Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List of Tables and Figures

Figure Cancer Treatment Drugs Picture
Table Product Specifications of Cancer Treatment Drugs
Figure North America Sales Market Share of Cancer Treatment Drugs by Types in 2016
Table Types of Cancer Treatment Drugs
Figure Chemotherapy Picture
Table Major Manufacturers of Chemotherapy
Figure Targeted Therapy Picture
Table Major Manufacturers of Targeted Therapy
Figure Immunotherapy Picture
Table Major Manufacturers of Immunotherapy
Figure Hormonal Therapy (Biologic Therapy) Picture
Table Major Manufacturers of Hormonal Therapy (Biologic Therapy)
Figure Others Picture
Table Major Manufacturers of Others
Table North America Cancer Treatment Drugs Sales Market Share by Applications in 2016
Table Applications of Cancer Treatment Drugs
Figure Blood Cancer Picture
Figure Breast Cancer Picture
Figure Gastrointestinal Cancer Picture
Figure Prostate Cancer Picture
Figure Respiratory/Lung Cancer Picture
Figure Other Cancers Picture
Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Treatment Drugs Type and Applications
Table Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cancer Treatment Drugs Type and Applications
Table Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Cancer Treatment Drugs Type and Applications
Table Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Cancer Treatment Drugs Type and Applications
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Treatment Drugs Type and Applications
Table Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cancer Treatment Drugs Type and Applications
Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cancer Treatment Drugs Type and Applications
Table Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Cancer Treatment Drugs Type and Applications
Table Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Cancer Treatment Drugs Type and Applications
Table Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cancer Treatment Drugs Type and Applications
Table AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Cancer Treatment Drugs Type and Applications
Table Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Cancer Treatment Drugs Type and Applications
Table Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Cancer Treatment Drugs Type and Applications
Table Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Cancer Treatment Drugs Type and Applications
Table Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Cancer Treatment Drugs Type and Applications
Table Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Cancer Treatment Drugs Type and Applications
Table Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Cancer Treatment Drugs Type and Applications
Table Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Cancer Treatment Drugs Type and Applications
Table Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck KGaA Basic Information, Manufacturing Base and Competitors
Table Merck KGaA Cancer Treatment Drugs Type and Applications
Table Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Cancer Treatment Drugs Type and Applications
Table Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Cancer Treatment Drugs Type and Applications
Table AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Cancer Treatment Drugs Type and Applications
Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure North America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure North America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table North America Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure North America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table North America Cancer Treatment Drugs Price by Manufacturers (2016-2017)
Figure Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2016
Figure Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2017
Figure Top 5 Cancer Treatment Drugs Manufacturer Market Share in 2016
Figure Top 5 Cancer Treatment Drugs Manufacturer Market Share in 2017
Figure North America Cancer Treatment Drugs Sales and Growth (2012-2017)
Table North America Cancer Treatment Drugs Sales by Countries (2012-2017)
Table North America Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
Figure North America 2012 Cancer Treatment Drugs Sales Market Share by Countries
Figure North America 2016 Cancer Treatment Drugs Sales Market Share by Countries
Figure North America Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table North America Cancer Treatment Drugs Revenue by Countries (2012-2017)
Table North America Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017)
Table North America 2012 Cancer Treatment Drugs Revenue Market Share by Countries
Table North America 2016 Cancer Treatment Drugs Revenue Market Share by Countries
Table North America Cancer Treatment Drugs Sales by Type (2012-2017)
Table North America Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table North America Cancer Treatment Drugs Revenue by Type (2012-2017)
Table North America Cancer Treatment Drugs Revenue Share by Type (2012-2017)
Figure North America Chemotherapy Sales Growth (2012-2017)
Figure North America Chemotherapy Price (2012-2017)
Figure North America Targeted Therapy Sales Growth (2012-2017)
Figure North America Targeted Therapy Price (2012-2017)
Figure North America Immunotherapy Sales Growth (2012-2017)
Figure North America Immunotherapy Price (2012-2017)
Figure North America Hormonal Therapy (Biologic Therapy) Sales Growth (2012-2017)
Figure North America Hormonal Therapy (Biologic Therapy) Price (2012-2017)
Figure North America Others Sales Growth (2012-2017)
Figure North America Others Price (2012-2017)
Table North America Cancer Treatment Drugs Sales by Application (2012-2017)
Table North America Cancer Treatment Drugs Sales Share by Application (2012-2017)
Figure North America Blood Cancer Sales Growth (2012-2017)
Figure North America Breast Cancer Sales Growth (2012-2017)
Figure North America Gastrointestinal Cancer Sales Growth (2012-2017)
Figure North America Prostate Cancer Sales Growth (2012-2017)
Figure North America Respiratory/Lung Cancer Sales Growth (2012-2017)
Figure North America Other Cancers Sales Growth (2012-2017)
Figure United States Cancer Treatment Drugs Revenue and Growth (2012-2017)
Figure United States Cancer Treatment Drugs Sales and Growth (2012-2017)
Table United States Cancer Treatment Drugs Sales by Type (2012-2017)
Table United States Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
Table United States Cancer Treatment Drugs Sales by Application (2012-2017)
Table United States Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
Table United States Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure United States Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure United States Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table United States Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure United States Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure United States Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table United States Cancer Treatment Drugs Export and Import (2012-2017)
Figure Canada Cancer Treatment Drugs Revenue and Growth (2012-2017)
Figure Canada Cancer Treatment Drugs Sales and Growth (2012-2017)
Table Canada Cancer Treatment Drugs Sales by Type (2012-2017)
Table Canada Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
Table Canada Cancer Treatment Drugs Sales by Application (2012-2017)
Table Canada Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
Table Canada Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Canada Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Canada Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Canada Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Canada Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Canada Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table Canada Cancer Treatment Drugs Export and Import (2012-2017)
Figure Mexico Cancer Treatment Drugs Revenue and Growth (2012-2017)
Figure Mexico Cancer Treatment Drugs Sales and Growth (2012-2017)
Table Mexico Cancer Treatment Drugs Sales by Type (2012-2017)
Table Mexico Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
Table Mexico Cancer Treatment Drugs Sales by Application (2012-2017)
Table Mexico Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
Table Mexico Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Mexico Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Mexico Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Mexico Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Mexico Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Mexico Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table Mexico Cancer Treatment Drugs Export and Import (2012-2017)
Figure North America Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)
Table North America Cancer Treatment Drugs Sales Forecast by Countries (2017-2022)
Table North America Cancer Treatment Drugs Market Share Forecast by Countries (2017-2022)
Figure United States Cancer Treatment Drugs Sales Forecast (2017-2022)
Figure Canada Cancer Treatment Drugs Sales Forecast (2017-2022)
Figure Mexico Cancer Treatment Drugs Sales Forecast (2017-2022)
Table North America Cancer Treatment Drugs Sales Forecast by Type (2017-2022)
Table North America Cancer Treatment Drugs Market Share Forecast by Type (2017-2022)
Table North America Cancer Treatment Drugs Sales Forecast by Application (2017-2022)
Table North America Cancer Treatment Drugs Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Treatment Drugs
Figure Manufacturing Process Analysis of Cancer Treatment Drugs
Figure Cancer Treatment Drugs Industrial Chain Analysis
Table Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016
Table Major Buyers of Cancer Treatment Drugs
Table Distributors/Traders/ Dealers List
  • EMEA (Europe, Middle East and Africa) Mitomycin C Market 2017 Forecast to 2022
    Published: 18-Jan-2018        Price: US 4480 Onwards        Pages: 116
    This report studies the Mitomycin C market, Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Scope of the Report: This report focuses on the Mitomycin C in EMEA market, covering Europe, Middle ......
  • Global Immunotherapy Drugs Sales Market Report 2018
    Published: 18-Jan-2018        Price: US 4000 Onwards        Pages: 104
    In this report, the global Immunotherapy Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Immunotherapy Drugs for these regions, from 2013 to 2025 (forecast), covering - United States - China - Europe - Ja......
  • Global Cancer Treatment Drugs Sales Market Report 2018
    Published: 18-Jan-2018        Price: US 4000 Onwards        Pages: 126
    In this report, the global Cancer Treatment Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Cancer Treatment Drugs for these regions, from 2013 to 2025 (forecast), covering - United States - China - Europe -......
  • North America Capecitabine Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 17-Jan-2018        Price: US 4480 Onwards        Pages: 121
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in North America market, especially in United States, Canada and Mexico. This report categorizes the market based o......
  • United States Multiple Myeloma Drugs Market Report 2018
    Published: 16-Jan-2018        Price: US 3800 Onwards        Pages: 103
    In this report, the United States Multiple Myeloma Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth r......
  • United States Docetaxel Market Report 2018
    Published: 16-Jan-2018        Price: US 3800 Onwards        Pages: 112
    In this report, the United States Docetaxel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Doceta......
  • Global and Chinese Doxorubicin Industry, 2018 Market Research Report
    Published: 15-Jan-2018        Price: US 3000 Onwards        Pages: 148
    The 'Global and Chinese Doxorubicin Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Doxorubicin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Doxorubicin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applic......
  • EMEA (Europe, Middle East and Africa) Paclitaxel Market 2017 Forecast to 2022
    Published: 15-Jan-2018        Price: US 4480 Onwards        Pages: 123
    Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol". Scope of the Report: This report focuses on the Paclitaxel in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, ty......
  • United States Cytotoxic Drug Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 15-Jan-2018        Price: US 4480 Onwards        Pages: 116
    Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably. Scope of th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs